200 related articles for article (PubMed ID: 11039173)
1. [Idiopathic thrombotic thrombocytopenic purpura or Moschowitz syndrome: current physiopathologic and therapeutic perspectives].
Retornaz F; Durand JM; Poullin P; Lefèvre P; Soubeyrand J
Rev Med Interne; 2000 Sep; 21(9):777-84. PubMed ID: 11039173
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.
Tsai HM; Lian EC
N Engl J Med; 1998 Nov; 339(22):1585-94. PubMed ID: 9828246
[TBL] [Abstract][Full Text] [Related]
3. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic thrombocytopenic purpura.
Koyfman A; Brém E; Chiang VW
Pediatr Emerg Care; 2011 Nov; 27(11):1085-8; quiz 1089-90. PubMed ID: 22068077
[TBL] [Abstract][Full Text] [Related]
5. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for thrombotic thrombocytopenic purpura.
Cataland SR; Wu HM
Curr Opin Hematol; 2005 Sep; 12(5):359-63. PubMed ID: 16093780
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
8. Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity.
Mori Y; Wada H; Gabazza EC; Minami N; Nobori T; Shiku H; Yagi H; Ishizashi H; Matsumoto M; Fujimura Y
Transfusion; 2002 May; 42(5):572-80. PubMed ID: 12084165
[TBL] [Abstract][Full Text] [Related]
9. An update on the pathogenesis and management of acquired thrombotic thrombocytopenic purpura.
Yarranton H; Machin SJ
Curr Opin Neurol; 2003 Jun; 16(3):367-73. PubMed ID: 12858075
[TBL] [Abstract][Full Text] [Related]
10. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura.
Tsai HM
J Am Soc Nephrol; 2003 Apr; 14(4):1072-81. PubMed ID: 12660343
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic thrombocytopenic purpura: from platelet aggregates to plasma.
Marques MB; Mayfield CA; Blackall DP
Am J Clin Pathol; 2004 Jun; 121 Suppl():S89-96. PubMed ID: 15298154
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic thrombocytopenic purpura mimicking an acute meningoencephalitis.
Tovoli F; De Giorgio R; Fabbri A; Serra M; Caio G; Grasso V; Felicani C; Barbara G; Volta U
Acta Clin Belg; 2011; 66(1):55-6. PubMed ID: 21485766
[TBL] [Abstract][Full Text] [Related]
13. Chronic relapsing thrombotic thrombocytopenic purpura due to a deficiency of von Willebrand factor-cleaving protease activity.
Stark GL; Wallis JP; Allford SL; Hanley J
Br J Haematol; 2002 Apr; 117(1):251-2. PubMed ID: 11918566
[No Abstract] [Full Text] [Related]
14. Schistocytic anaemia, severe thrombocytopenia, and renal dysfunction: thrombotic microangiopathy due to severe acquired ADAMTS-13 deficiency. Case 2.
Winkler A; Kremer Hovinga JA; Bianchi V; Studt JD; Lämmle B
Hamostaseologie; 2003 Aug; 23(3):103-8. PubMed ID: 12923577
[TBL] [Abstract][Full Text] [Related]
15. Thrombotic thrombocytopenic purpura: advances in pathophysiology, diagnosis, and treatment--introduction.
Lämmle B; George JN
Semin Hematol; 2004 Jan; 41(1):1-3. PubMed ID: 14727253
[No Abstract] [Full Text] [Related]
16. Deficiency of ADAMTS13 in thrombotic thrombocytopenic purpura.
Tsai HM
Int J Hematol; 2002 Aug; 76 Suppl 2():132-8. PubMed ID: 12430913
[TBL] [Abstract][Full Text] [Related]
17. [Progress on TTP/HUS diagnosis with analysis of VWF-cleaving protease activation].
Fujimura Y
Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):451-9. PubMed ID: 15052802
[No Abstract] [Full Text] [Related]
18. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
Furlan M
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
[TBL] [Abstract][Full Text] [Related]
19. Thrombotic thrombocytopenic purpura attributable to von Willebrand factor-cleaving protease inhibitor in an 8-year-old boy.
Robson WL; Tsai HM
Pediatrics; 2002 Feb; 109(2):322-5. PubMed ID: 11826215
[No Abstract] [Full Text] [Related]
20. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
Kato S; Fujimura Y
Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
